Exciva

German biotech founded in 2016 in Heidelberg that closed a EUR 51M Series B in January 2026.

View on the globe

$59MEquity raised in 2025–20262025 — · 2026 $59M · 1 equity round
$59MEquity raised, all time1 equity round sourced so far
—Latest valuationnot disclosed

Rounds over time log-scaled amounts

Funding history: 1 round from 20 Jan 2026 to 20 Jan 2026, $59M equity disclosed. Earlier rounds exist but are not sourced.20 Jan 2026: Series B, $59M$1M$3M$10M$30M$100MEarlier rounds exist but are not sourced yet← earlier rounds not sourcedest. 2016Q3Q42026Q2Q3Q4Equity round20 Jan 2026 · Series B · $59M · led by Gimv, EQT Life SciencesSeries B · $59M
Funding history: 1 round from 20 Jan 2026 to 20 Jan 2026, $59M equity disclosed. Earlier rounds exist but are not sourced.20 Jan 2026: Series B, $59M$1M$3M$10M$30M$100MEarlier rounds exist but are not sourced yetearlier rounds not sourced’16Q3Q42026Q2Q3Q4Equity round20 Jan 2026 · Series B · $59M · led by Gimv, EQT Life Sciences$59M

Funding history 1 round · 1 source

Earlier rounds not yet sourced. Exciva was founded in 2016 and raised before 20 Jan 2026; only the rounds below are sourced so far, so its all-time equity total understates its history.

  1. Series B
    Amount$59MEUR 51M
    Post-money—
    ✓ Confirmed
    Lead
    Gimv, EQT Life Sciences
    Also
    Fountain Healthcare Partners, LifeArc Ventures, Carma Fund, Modi Ventures, Andera Partners, LBBW
    Note
    Company release dated 20 Jan 2026 (Heidelberg dateline): EUR 51M (about $59M, the company's own conversion, stored as amountUsd with amountNative EUR) Series B co-led by Gimv and EQT Life Sciences. New investors Fountain Healthcare Partners, LifeArc Ventures, Carma Fund and Modi Ventures; existing investors Andera Partners and LBBW. Valuation not disclosed; pre- or post-money not stated.
    Sources
  2. Earlier rounds not yet sourced

Investors 8

  • EQT Life Sciences1
  • Gimv1
  • Andera Partners
  • Carma Fund
  • Fountain Healthcare Partners
  • LBBW
  • LifeArc Ventures
  • Modi Ventures

Highlighted investors led at least one equity round; the number is equity rounds taken part in.

Related companies shared investors

Figures in USD at the time of each round. See the methodology for how rounds are sourced and verified. Exciva and its logo are trademarks of their owners, used here for identification only.